Page Archive | Expertomega3

High EPA plasma levels are associated with a lower risk of Alzheimer’s disease
- 09/13/2018
The neuroprotective properties of polyunsaturated fatty acids (PUFAs) are well established (especially for docosahexaenoic acid (DHA)) and there is growing evidence to support its protective effect in Alzheimer’s disease. The 2018 Alzheimer's Association International Conference, held in Chicago,...

Read more
Omega-3 PUFA supplementation provides beneficial effects on cardiometabolic markers and glycaemic control in diabetes mellitus type 2
- 09/17/2018
Cardiovascular disease is the main cause of morbidity and mortality in people with diabetes mellitus type 2 (DMT2) and glycaemic control, the key objective in antidiabetic control, only has a marginal effect on cardiovascular risk. However, correcting cardiometabolic parameters (e.g. lipid...

Read more
The importance of taking omega 6 into consideration when assessing the effects of omega 3 on myocardial infarction
- 09/28/2018
Experimentally, omega-3 polyunsaturated fatty acids (PUFAs) have been shown to have beneficial cardiovascular effects, including reducing the myocardial infarct size. However, results from recent clinical trials suggest a lesser role for omega-3 PUFAs in cardiovascular health. The dichotomy between...

Read more

High EPA plasma levels are associated with a lower risk of Alzheimer’s disease